Investigation of novel pharmacological vulnerabilities of 9p21-deleted bladder cancer cells

UroToday, Commentary by Cora Sternbeg

The INSIDE-PC study provides evidence of the potential of AI systems in medical literature searches on complex clinical questions.

12 Jul

ESMO Congress 2024

ESMO Congress 2024 - European Society for Medical Oncology Barcellona 13-17 Settembre 2024

27 May

Efficacy and Safety of Darolutamide in Combination With ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study

In this video Cora Sternberg talks about efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel by disease, volume and risk in the phase three Arasens study.

27 May

Urothelial Carcinoma: New Developments

In this video Dr. Cora Sternberg discusses new developments in the treatment of urothelial carcinoma.

02 Jen

AKT Inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis - Cora Sternberg

In this interview for UroToday dr. Cora Sternberg presents the latest data and ongoing clinical trials in the context of prostate cancer.

04 Dec

The EV-302 Study and the Implications for Metastatic Bladder Cancer Care

Alicia Morgans speaks with Cora Sternberg about the EV-302 study presented at ESMO 2023. This study marks a significant shift in treating advanced metastatic urothelial cancer, traditionally managed with cisplatin or carboplatin-based chemotherapy.

27 Oct

Exploration of therapeutic vulnerabilities exposed by 9p21 loss in bladder cancer cell lines.

11 Oct

Congresses

SIU Congress 2023

Dr. Cora Sternberg lecture: Precision medicine for prostate cancer

05 Jul

Precision Medicine

Precision medicine is an emerging approach to the treatment and prevention of diseases that takes into account the individual variability of each person's genes, environment and lifestyle.

22 Jun

Projects

The Samuel and Barbara Research Foundation call for applications is open year long. Fellowships are available to those working in Italy in the field of Cancer research or related to cancer research.

04 Jun

Cancer Statistics

In the EU, 1,269,200 cancer deaths are expected in 2022; the corresponding age-standardized rates (world) fall by 6% to 126.9 deaths/100,000 in men and by 4% to 80.2/100,000 in women since 2017.

02 Jun

Congresses

Treatment Approach for Patients With Cisplatin-Eligible Bladder Cancer

A panel discussion, moderated by Vadim Koshkin, MD, of the University of California, San Francisco, features Dr. Cora Sternberg.